Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

ClinicalTrials.gov ID: NCT01436149

Public ClinicalTrials.gov record NCT01436149. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 4:16 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

The SPD489-322 Phase 3, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Flexible Dose Titration, Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder With Inadequate Response to Prospective Treatment With an Antidepressant

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will examine SPD489 in subjects aged 18-65 with major depressive disorder (MDD) who are taking certain types of antidepressants but continue to have residual depression symptoms. Eligible patients will remain on their antidepressant but will be randomized to either receive supplemental SPD489 or placebo (i.e. sugar pill). The purpose of this study is to help answer the following questions: * How safe is SPD489 for the supplemental treatment of depression and what are the side effects that might be related to it? * Can supplemental SPD489 help patients who still have residual depression symptoms while taking an antidepressant? * How much SPD489 should be given to patients with depression who are also taking an antidepressant? * How does SPD489 compare to placebo in depressed patients who are also taking an antidepressant?

Study identification

NCT ID
NCT01436149
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Shire
Industry
Enrollment
1,262 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 27, 2011 (Actual)
Primary completion
Dec 23, 2013 (Actual)
Completion
Dec 23, 2013 (Actual)
Last update posted
Jun 9, 2021

2011 – 2013

United States locations

U.S. sites
47
U.S. states
22
U.S. cities
45
Facility City State ZIP Site status
Birmingham Research Group Birmingham Alabama 35216 —
AV Institue, Inc. Carson California 90746 —
University of California, Irvine Child Development Center Irvine California 92612 —
South Coast Clinicals Norwalk California 90650 —
North County Clinical Research Oceanside California 92056 —
Pasadena Research Institute, LLC Pasadena California 91106 —
Affiliated Research Institute San Diego California 92108 —
Clinical Innovations, Inc. San Diego California 92121 —
Sharp Mesa Vista Hospital San Diego California 92123 —
Geriatric and Adult Psychiatry, LLC Hamden Connecticut 06518 —
Middlexex Hospital Center for Behavioral Health Middletown Connecticut 06457 —
CNS Clinical Research Group Coral Springs Florida 33067 —
Emerald Coast Mood & Memory, PA Fort Walton Beach Florida 32547 —
Florida Clinical Research Center, LLC. Maitland Florida 32751 —
Suncoast Clinical Research New Port Richey Florida 34652 —
Compass Research, LLC Orlando Florida 32806 —
Meridien Research St. Petersburg Florida 33709 —
Stedman Clinical Trials Tampa Florida 33613 —
Carman Research Smyrna Georgia 30080 —
American Medical Research, Inc. Oak Brook Illinois 60523 —
The Davis Clinic Indianapolis Indiana 46260 —
Northwest Indiana Center for Clinical Research Valparaiso Indiana 46383 —
MCM Clinical Research LLC Florence Kentucky 41042 —
Pharmasite Research, Inc. Baltimore Maryland 21208 —
Potomac Grove Clinical Research Center Gaithersburg Maryland 20877 —
Office of Marc Hertzman, MD Rockville Maryland 20852 —
Adams Clinical Trials, LLC Watertown Massachusetts 02472 —
St. Charles Psychiatric Associates - Midwest Research Group Saint Charles Missouri 63301 —
Bioscience Research, LLC Mount Kisco New York 10549 —
Fieve Clinical Research New York New York 10168 —
Richmond Behavioral Associates Staten Island New York 10312 —
Triangle Neuropsychiatry Durham North Carolina 27707 —
Rcihard H. Weisler, MD, PA & Associates Raleigh North Carolina 27809 —
Community Research Cincinnati Ohio 45227 —
Lindner Center of HOPE Mason Ohio 45040 —
SP Research, PLLC Oklahoma City Oklahoma 73112 —
Summit Research Network (Oregon) Inc. Portland Oregon 97210 —
Paramount Clinical Research Bridgeville Pennsylvania 15107 —
Suburban Research Associates Media Pennsylvania 19063 —
CRI Worldwide LLC Philadelphia Pennsylvania 19139 —
University of Pittsburgh School of Medicine Pittsburgh Pennsylvania 15213 —
Rhode Island Mood & Memory Research Institute East Providence Rhode Island 02914 —
Clinical Neuroscience Solutions, Inc. Memphis Tennessee 38119 —
Clinical Research Associates Nashville Tennessee 37203 —
FutureSearch Clinical Trials, LP Austin Texas 78731 —
Ericksen Research and Development Clinton Utah 84015 —
Summit Research Network (Seattle) LLC Seattle Washington 98104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01436149, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 9, 2021 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01436149 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →